284 related articles for article (PubMed ID: 12598334)
21. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
[TBL] [Abstract][Full Text] [Related]
22. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
23. Traditional and emerging molecular markers in neuroblastoma prognosis: the good, the bad and the ugly.
Poremba C; Hero B; Goertz HG; Scheel C; Wai D; Schaefer KL; Christiansen H; Berthold F; Juergens H; Boecker W; Dockhorn-Dworniczak B
Klin Padiatr; 2001; 213(4):186-90. PubMed ID: 11528552
[TBL] [Abstract][Full Text] [Related]
24. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
25. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
Saebøe-Larssen S; Fossberg E; Gaudernack G
BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
[TBL] [Abstract][Full Text] [Related]
26. A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Sugimoto T; Gotoh T; Yagyu S; Kuroda H; Iehara T; Hosoi H; Ohta S; Ohira M; Nakagawara A
Cancer Lett; 2013 Apr; 331(1):115-21. PubMed ID: 23268333
[TBL] [Abstract][Full Text] [Related]
27. Correlations between the expression of hTERT and α and β splice variants in human brain tumors.
Khajehgoodari R; Khorvash F; Kheirollahi M; Mirsafaie M; Salehi M
Adv Clin Exp Med; 2019 Apr; 28(4):507-513. PubMed ID: 31044567
[TBL] [Abstract][Full Text] [Related]
28. Expression of inhibitor-of-apoptosis protein (IAP) livin by neuroblastoma cells: correlation with prognostic factors and outcome.
Kim DK; Alvarado CS; Abramowsky CR; Gu L; Zhou M; Soe MM; Sullivan K; George B; Schemankewitz E; Findley HW
Pediatr Dev Pathol; 2005; 8(6):621-9. PubMed ID: 16328668
[TBL] [Abstract][Full Text] [Related]
29. Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.
Wang Y; Kowalski J; Tsai HL; Marik R; Prasad N; Somervell H; Lo PK; Sangenario LE; Dyrskjot L; Orntoft TF; Westra WH; Meeker AK; Eshleman JR; Umbricht CB; Zeiger MA
Thyroid; 2008 Oct; 18(10):1055-63. PubMed ID: 18816183
[TBL] [Abstract][Full Text] [Related]
30. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
Raggi CC; Maggi M; Renzi D; Calabrò A; Bagnoni ML; Scaruffi P; Tonini GP; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
J Clin Endocrinol Metab; 2000 Oct; 85(10):3866-73. PubMed ID: 11061551
[TBL] [Abstract][Full Text] [Related]
31. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
32. MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients.
Chang HH; Tseng YF; Lu MY; Yang YL; Chou SW; Lin DT; Lin KH; Jou ST; Hsu WM; Jeng YM
Mod Pathol; 2020 Apr; 33(4):531-540. PubMed ID: 31695155
[TBL] [Abstract][Full Text] [Related]
33. Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant.
Lincz LF; Mudge LM; Scorgie FE; Sakoff JA; Hamilton CS; Seldon M
Neoplasia; 2008 Oct; 10(10):1131-7. PubMed ID: 18813352
[TBL] [Abstract][Full Text] [Related]
34. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
[TBL] [Abstract][Full Text] [Related]
35. Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas.
Poremba C; Hero B; Heine B; Scheel C; Schaefer KL; Christiansen H; Berthold F; Kneif S; Stein H; Juergens H; Boecker W; Dockhorn-Dworniczak B
Med Pediatr Oncol; 2000 Dec; 35(6):651-5. PubMed ID: 11107139
[TBL] [Abstract][Full Text] [Related]
36. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.
Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; Carey LA; Grundy PE; Perlman EJ; Breslow NE; Sukumar S
Cancer Res; 1999 Sep; 59(17):4301-7. PubMed ID: 10485476
[TBL] [Abstract][Full Text] [Related]
37. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Poremba C; Willenbring H; Hero B; Christiansen H; Schäfer KL; Brinkschmidt C; Jürgens H; Böcker W; Dockhorn-Dworniczak B
Ann Oncol; 1999 Jun; 10(6):715-21. PubMed ID: 10442195
[TBL] [Abstract][Full Text] [Related]
38. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
Cancer Res; 1998 Sep; 58(18):4168-72. PubMed ID: 9751630
[TBL] [Abstract][Full Text] [Related]
39. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
40. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
